ACS Medicinal Chemistry Letters · 2014 · 67 citations · 9 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryEnzymologyAllosteric Drug DesignAllosteric RecognitionAllosteric RegulationConformational SelectionEnzyme InhibitionAllosteric Drug DiscoveryAllosteric InhibitionAllosteric Inhibition MechanismsAllosteric Kinase InhibitorsAllosteric KineticsHinge Region StructureKinase InhibitorsProtein Kinase Inhibitors
The first allosteric, type III inhibitor of LIM-kinase 2 (LIMK2) is reported. A series of molecules that feature both an N-phenylsulfonamide and tertiary amide were not only very potent at LIMK2 but also were extremely selective against a panel of other kinases. Enzymatic kinetic studies showed these molecules to be noncompetitive with ATP, suggesting allosteric inhibition. X-ray crystallography confirmed that these sulfonamides are a rare example of a type III kinase inhibitor that binds away from the highly conserved hinge region and instead resides in the hydrophobic pocket formed in the DFG-out conformation of the kinase, thus accounting for the high level of selectivity observed.
9
The Determination of Enzyme Dissociation Constants
Hans Lineweaver, Dean Burk · Journal of the American Chemical Society · 1934 · 12.1K citations
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Thomas H. Schindler, William G. Bornmann, Patricia Pellicena et al. · Science · 2000 · 1.8K citations
A Novel Method for Measurement of Submembrane ATP Concentration
Fiona M. Gribble, Gildas Loussouarn, Stephen J. Tucker et al. · Journal of Biological Chemistry · 2000 · 275 citations · Full text
Justin Dietrich, Christopher Hulme, Laurence H. Hurley · Bioorganic & Medicinal Chemistry · 2010 · 182 citations · Full text